108 related articles for article (PubMed ID: 1909275)
1. Treatment of chronic hepatitis C with weekly administration of interferon-alpha.
Morizane T; Kagawa T; Saito H; Guevara FM; Miyaguchi S; Tsuchiya M
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():254-5. PubMed ID: 1909275
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic non-A, non-B hepatitis with interferon.
Karino Y; Matsushima T; Saga A; Tsuyuguchi M; Miyazaki T; Toyota J
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():234-8. PubMed ID: 1909272
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.
Arase Y; Kumada H; Chayama K; Tsubota A; Ikeda K; Saitoh S; Sakai Y; Matsumoto T; Kobayashi M
Gastroenterol Jpn; 1992 Oct; 27(5):646-51. PubMed ID: 1330798
[TBL] [Abstract][Full Text] [Related]
5. Interferon therapy for non-A, non-B chronic hepatitis.
Iino S; Hino K; Kondo T; Koike K; Yasuda K; Yotsuyanagi H; Kurokawa K
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():224-9. PubMed ID: 1653164
[TBL] [Abstract][Full Text] [Related]
6. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha.
Bresci G; Parisi G; Banti S; Capzia A
J Viral Hepat; 1995; 2(3):155-8. PubMed ID: 7493311
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of weekly administration of lymphoblastoid interferon in patients with chronic hepatitis C.
Kagawa T; Morizane T; Saito H; Miyaguchi S; Tsunematsu S; Tada S; Guevara FM; Kumagai N; Tsuchimoto K; Watanabe T
J Hepatol; 1993 Jan; 17(1):91-6. PubMed ID: 8445225
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
[TBL] [Abstract][Full Text] [Related]
10. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
Omata M; Ito Y; Yokosuka O; Imazeki F; Tagawa M; Takano S; Hosoda K; Tada M; Ohto M; Ito K
Dig Dis Sci; 1991 Sep; 36(9):1217-22. PubMed ID: 1654240
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
15. One course versus two courses of recombinant alpha interferon in chronic C hepatitis.
Taliani G; Furlan C; Grimaldi F; Clementi C; Lecce R; Manganaro M; Duca F; De Bac C
Arch Virol Suppl; 1992; 4():294-8. PubMed ID: 1450706
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.
Hwang SJ; Chan CY; Lu RH; Wu JC; Lee SD
J Interferon Cytokine Res; 1995 Jul; 15(7):611-6. PubMed ID: 7553231
[TBL] [Abstract][Full Text] [Related]
18. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
Sáez-Royuela F; Porres JC; Moreno A; Castillo I; Martinez G; Galiana F; Carreño V
Hepatology; 1991 Feb; 13(2):327-31. PubMed ID: 1899852
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: results of a long-term follow-up trial.
Tanaka K; Kondo M; Sakaguchi T; Saito S; Arata S; Ikeda M; Kitamura T; Morimoto M; Sekihara H
J Gastroenterol Hepatol; 1996 Dec; 11(12):1155-60. PubMed ID: 9034935
[TBL] [Abstract][Full Text] [Related]
20. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
